AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-3.65%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.36B
AUM Growth
+$3.36B
(-16%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
302
New
82
Increased
55
Reduced
75
Closed
50
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$65.3M |
| 2 |
Immunovant
IMVT
|
$39.8M |
| 3 |
AB InBev
BUD
|
$38.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$33.3M |
| 5 |
Charles River Laboratories
CRL
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$114M |
| 2 |
Pfizer
PFE
|
$76.9M |
| 3 |
Johnson & Johnson
JNJ
|
$50.7M |
| 4 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 5 |
Incyte
INCY
|
$42.7M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Consumer Staples | 12.81% |
| 3 | Technology | 8.13% |
| 4 | Consumer Discretionary | 7.55% |
| 5 | Communication Services | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Chipotle Mexican Grill
CMG
$56.5B
| $11.8M | 0.18% | 6,425 +1,575 | +32% | +$2.89M |
|
77
Foot Locker
FL
$2.36B
| $11.5M | 0.18% | 664,657 +174,657 | +36% | +$3.03M |
|
78
Philip Morris
PM
$260B
| $11.2M | 0.17% | 121,249 -102,751 | -46% | -$9.51M |
|
79
Dyne Therapeutics
DYN
$1.92B
| $10.8M | 0.16% | 1,200,000 +288,000 | +32% | +$2.58M |
|
80
Thermo Fisher Scientific
TMO
$186B
| $10.6M | 0.16% | 21,000 -24,000 | -53% | -$12.1M |
|
81
Zura Bio
ZURA
$133M
| $10.4M | 0.16% | 1,580,000 +630,000 | +66% | +$4.16M |
|
82
Alibaba
BABA
$322B
| $10.4M | 0.16% | 120,000 -180,000 | -60% | -$15.6M |
|
83
GSK
GSK
$79.9B
| $10.3M | 0.16% | 285,000 -15,000 | -5% | -$544K |
|
84
Assertio
ASRT
$80.4M
| $10M | 0.15% | +3,924,000 | New | +$10M |
|
85
Celsius Holdings
CELH
$16.2B
| $9.95M | 0.15% | +58,000 | New | +$9.95M |
|
86
UiPath
PATH
$5.95B
| $9.79M | 0.15% | 572,189 -91,811 | -14% | -$1.57M |
|
87
Adobe
ADBE
$151B
| $9.08M | 0.14% | 17,804 -6,196 | -26% | -$3.16M |
|
88
lululemon athletica
LULU
$24.2B
| $8.84M | 0.14% | 22,932 -12,068 | -34% | -$4.65M |
|
89
Applied Therapeutics
APLT
$71M
| $8.47M | 0.13% | +3,400,000 | New | +$8.47M |
|
90
NVIDIA
NVDA
$4.24T
| $7.78M | 0.12% | 17,879 -121 | -0.7% | -$52.6K |
|
|
FREE
91
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $7.74M | 0.12% | 2,150,000 | – | – |
|
92
Geron
GERN
$893M
| $7.68M | 0.12% | 3,624,000 -876,000 | -19% | -$1.86M |
|
93
TSMC
TSM
$1.2T
| $7.65M | 0.12% | 88,000 +16,000 | +22% | +$1.39M |
|
94
Crocs
CROX
$4.76B
| $7.35M | 0.11% | 83,360 -11,640 | -12% | -$1.03M |
|
95
Aquestive Therapeutics
AQST
$456M
| $7.34M | 0.11% | 4,800,000 +3,642,000 | +315% | +$5.57M |
|
|
GB
96
DELISTED
Global Blue Group Holding
GB
| $7.3M | 0.11% | 1,199,875 -325,125 | -21% | -$1.98M |
|
|
SPRB
97
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $6.91M | 0.11% | 3,056,000 -442,000 | -13% | -$999K |
|
98
FibroGen
FGEN
$47.8M
| $6.81M | 0.1% | 7,892,000 +3,536,000 | +81% | +$3.05M |
|
99
Pinduoduo
PDD
$171B
| $6.67M | 0.1% | +68,000 | New | +$6.67M |
|
|
NARI
100
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $6.59M | 0.1% | 100,732 -87,268 | -46% | -$5.71M |
|